Surmodics Reports Fourth Quarter Fiscal 2021 Results and Issues Fiscal 2022 Revenue and EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rises as oil slide offers respite after Fed rate hike
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Paradium AI (PAAI) Halted, News Pending
SurModics (SRDX) PT Lowered to $70 at Needham & Company
November 10, 2021 12:10 PM ESTNeedham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $70.00 (from $76.00) while maintaining a Buy rating.
The analyst commented, "SRDX's F4Q21 revenue and EPS beat consensus. Initial FY22 revenue and EPS guidance was well below consensus... More
SurModics (SRDX) Tops Q4 EPS by 15c
November 10, 2021 7:37 AM ESTSurModics (NASDAQ: SRDX) reported Q4 EPS of ($0.10), $0.15 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $24 million versus the consensus estimate of $23.06 million.
GUIDANCE:
SurModics sees FY2022 EPS of ($1.75)-($1.25), versus the consensus of $0.21. SurModics sees... More
